CJC-1295 with DAC is a synthetic peptide designed to stimulate the release of growth hormone, offering extended activity and enhanced therapeutic benefits compared to other growth hormone-releasing peptides.
By binding to growth hormone-releasing hormone (GHRH) receptors, CJC-1295 promotes a sustained increase in growth hormone and IGF-1 levels, which are essential for cell regeneration, fat metabolism, and muscle growth.
This peptide’s unique DAC (Drug Affinity Complex) technology ensures prolonged half-life and a steady release, making it ideal for long-term research into growth hormone therapies.
CJC-1295 with DAC has shown promise in studies for its potential to improve body composition, accelerate recovery, and support anti-aging effects by enhancing overall metabolic function and cellular repair.
Perfect for researchers exploring innovative approaches to growth hormone optimization, CJC-1295 with DAC  provides a reliable and potent solution for scientific investigation.